SA

Sajjad Abdul Gafoor Sayyad

Active Director Director DIN 10130116
DIN 10130116 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sajjad Abdul Gafoor Sayyad

Data last updated:

Sajjad Abdul Gafoor Sayyad is a Director at Virush Biotech Private Limited (since 2023). The company operates in Paper.

DIN 10130116
Primary Designation Director
Industry Paper
First Appointment 24 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Virush Biotech Private Limited U21001MH2023PTC401491
Director24 Apr 20232023Active

Board colleagues of Sajjad Abdul Gafoor Sayyad

Directorship timeline

Open interactive timeline →
Virush Biotech Private Limited
Premium access

Shareholding and investment profile for Sajjad Abdul Gafoor Sayyad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sajjad Abdul Gafoor Sayyad

Sajjad Abdul Gafoor Sayyad currently holds 1 directorship: Virush Biotech Private Limited (Director, since 24 Apr 2023).

Sajjad Abdul Gafoor Sayyad was first appointed on 24 Apr 2023 as Director at Virush Biotech Private Limited.

The current boards of Sajjad Abdul Gafoor Sayyad's companies include Jayesh Markendeshwar Dhapkas (Virush Biotech Private Limited), Rupa Jayesh Dhapkas (Virush Biotech Private Limited), Shabanam Sajjad Sayyad (Virush Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available